Virion Therapeutics, LLC Company Profile, Contacts & Intelligence

Biotechnology ResearchNewark, De, United States8 employeesFounded 2018
2 contacts with email or phone data2 with email data1 with phone data
View verified contacts Compare competitors
Employees
8
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 3 visible contacts

Virion Therapeutics, LLC Overview

At Virion Therapeutics, We Believe a Future Free of Cancer and Chronic Infectious Diseases Is Within Reach Driven by science, our mission is to revolutionize the immunotherapy treatment landscape, focusing on the development of novel, adaptable, and accessible CD8+ T cell-based technologies. Our transformative platform is first in its class, offering a unique methodology that combines innovative and established approaches to elicit a superior CD8+ T cell response. Novel genetically encoded checkpoint modifiers are delivered alongside optimized target-specific antigens via an immunogenic and adaptable viral vector platform that promotes potent, prolonged, and broad CD8+ T cell responses. With potential applications across a range of cancers and chronic infectious diseases, our proprietary technology provides us with a robust pipeline. Our lead product, VRON-0200, is under investigation as a potential functional cure for the treatment of chronic hepatitis B virus (HBV) – a first-in-human clinical study is planned to initiate in late 2022. Founded in 2018 to advance technology licensed from The Wistar Institute, we have assembled a world-class management team and an industry-leading global Board of Directors, with proven experience in the biotechnology sector, as well as extensive preclinical and clinical expertise in antiviral, vaccine, oncology, and immuno-oncology.

Headquarters
Newark, De, United States
Website
www.viriontx.com
Industry
Biotechnology Research
Founded
2018
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Infectious diseases Cancer Immunotherapy

Virion Therapeutics, LLC Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.

Virion Therapeutics, LLC People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

J
Janice Bennett
Director Cmc at Virion Therapeutics
E
L
Larissa Haut, Ph.d.
Head of Early-stage Cmc at Virion Therapeutics
A
Andrew Luber
President & CEO at Virion Therapeutics, Llc
EP

Virion Therapeutics, LLC Workforce Composition

Seniority breakdown across 3 visible profiles.

Executive
1
VP / Head
1
Director
1

Compare Similar Companies to Virion Therapeutics, LLC

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Cardax, Inc. Pharmaceutical Manufacturing 17 View company
NRx Pharmaceuticals, Inc. Biotechnology Research 14 View company
Avobis Bio Biotechnology Research 11 View company
Speratum Biopharma, Inc. Biotechnology Research 8 View company
OCEAN BIOMEDICAL Biotechnology Research 7 View company
GABA Therapeutics, Inc Biotechnology Research 6 View company
Virion Biotherapeutics Biotechnology 4 View company
Zepteon, Inc. Biotechnology Research 4 View company
Eilean Therapeutics Biotechnology Research 3 View company
Nektar Therapeutics Biotechnology Not listed View company